Polymer-based Non-viral Gene Delivery As a Concept for the Treatment of Cancer
Overview
Affiliations
Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNA from the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.
Nalkiran I, Sevim Nalkiran H Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005959 PMC: 11859872. DOI: 10.3390/ph18020144.
Karagoz U, Kc R, Isel E, Kantarci A, Uludag H Turk J Pharm Sci. 2024; 21(5):449-455.
PMID: 39569682 PMC: 11600320. DOI: 10.4274/tjps.galenos.2023.72430.
Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement.
Alekseenko I, Kuzmich A, Kondratyeva L, Kondratieva S, Pleshkan V, Sverdlov E Int J Mol Sci. 2021; 22(17).
PMID: 34502287 PMC: 8430744. DOI: 10.3390/ijms22179376.
Bluetongue Virus Particles as Nanoreactors for Enzyme Delivery and Cancer Therapy.
Thuenemann E, Le D, Lomonossoff G, Steinmetz N Mol Pharm. 2021; 18(3):1150-1156.
PMID: 33566625 PMC: 8086382. DOI: 10.1021/acs.molpharmaceut.0c01053.
Novel Histone-Based DNA Carrier Targeting Cancer-Associated Fibroblasts.
Kuzmich A, Rakitina O, Didych D, Potapov V, Zinovyeva M, Alekseenko I Polymers (Basel). 2020; 12(8).
PMID: 32751200 PMC: 7464289. DOI: 10.3390/polym12081695.